This report provides an executive summary of an analysis of Australian Pharmaceutical Industries Limited (API Ltd), focusing on the application of accounting theories, particularly positive and normative practices. The assessment includes a review of API's accounting policies, principles, and estimates, evaluating their flexibility, and comparing them to competitors like Sigma Healthcare. The report examines pressures influencing accounting standards, implications of accounting choices, and presents an investigative report on the managers' accounting and reporting strategies. The analysis incorporates the importance of AASB, IASB, and the Corporations Act 2001, evaluating accounting quality, identifying potential red flags, and assessing compliance with the conceptual framework. The report concludes with an overview of the key findings and recommendations regarding API's financial reporting practices.
![[object Object]](/_next/static/media/star-bottom.7253800d.svg)
